El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Miniatura

Fitxers

701890.pdf (4.23 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2019-10-01

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/171258

Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1172/JCI129987

Resum

Parkinson's disease (PD) is a common neurodegenerative disease that lacks therapies to prevent progressive neurodegeneration. Impaired energy metabolism and reduced ATP levels are common features of PD. Previous studies revealed that terazosin (TZ) enhances the activity of phosphoglycerate kinase 1 (PGK1), thereby stimulating glycolysis and increasing cellular ATP levels. Therefore, we asked whether enhancement of PGK1 activity would change the course of PD. In toxin-induced and genetic PD models in mice, rats, flies, and induced pluripotent stem cells, TZ increased brain ATP levels and slowed or prevented neuron loss. The drug increased dopamine levels and partially restored motor function. Because TZ is prescribed clinically, we also interrogated 2 distinct human databases. We found slower disease progression, decreased PD-related complications, and a reduced frequency of PD diagnoses in individuals taking TZ and related drugs. These findings suggest that enhancing PGK1 activity and increasing glycolysis may slow neurodegeneration in PD.

Matèries

Malaltia de Parkinson, Malalties neurodegeneratives

Matèries (anglès)

Parkinson's disease, Neurodegenerative Diseases

Citació

Col·leccions

Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

CAI, Rong, ZHANG, Yu, SIMMERING, Jacob e., SCHULTZ, Jordan l., LI, Yuhong, FERNÁNDEZ CARASA, Irene, CONSIGLIO, Antonella, RAYA CHAMORRO, Ángel, POLGREEN, Philip m., NARAYANAN, Nandakumar s., YUAN, Yanpeng, CHEN, Zhiguo, SU, Wenting, HAN, Yanping, ZHAO, Chunyue, GAO, Lifang, JI, Xunming, WELSH, Michael j., LI, Lei. Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases. _Journal of Clinical Investigation_. 2019. Vol. 129, núm. 10, pàgs. 4539-4549. [consulta: 6 de gener de 2026]. ISSN: 0021-9738. [Disponible a: https://hdl.handle.net/2445/171258]

Exportar metadades

JSON - METS

Compartir registre